What's new in IDIS/Web:

 • New Drugs

 • Drug Name/Code Changes

 • FDA Approval Packages

 • Advisory Committee Meetings

 • Priority Clinical Practice Guidelines

 • Continuing Education Articles

 

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 

 

Email: idis@uiowa.edu


Drug Information Resources

Notice: IDIS database discontinuation December 31, 2014.   Read more.

IDIS Logo   IDIS Monthly Update Information - June 2012

NEW DRUG TERM
ACOTIAMIDE
ALIPOGENE TIPARVOVEC
APOCYNUM VENETUM
AT-9283
CARBON C 11 TIC-ME
CEFTOLOZANE
DABRAFENIB
FERROQUINE
GANITUMAB
GANTENERUMAB
IMM-101
MIRABEGRON
MITRAGYNA SPECIOSA
PAQUINIMOD
PD-0360324
PF-00562271
RGD-K5, F 18
TC 99M 3PRGD2

CODE
56400045
14000813
92510286
10121018
36680127
8120676
10121021
8200024
10120298
82000565
10121019
12080105
92510287
14000083
82000566
10121020
36680128
78040276


DRUG NAME/CODE CHANGES

OLD TERM & CODENEW TERM & CODE
DIMEBON 92000309LATREPIRDINE 92000309
GA-101 10120276OBINUTUZUMAB 10120276
IDX-899 8180875GSK-2248761 8180875
LC-150444 68200434GEMIGLIPTIN 8200434
OPC-67683 8160012DELAMANID 8160012
SINAPULTIDE 92000124LUCINACTANT 92000124
TOREZOLID 8122952TEDIZOLID 8122952
TRASTUZUMAB-DM-1 82000541TRASTUZUMAB EMTANSINE 82000541


FDA APPROVAL PACKAGES

Article Numbers 677810-677824: Lucinactant, Surfaxin Intratracheal Suspension, FDA Approval Package for NDA 21-746. FDA Approval Package 2012.

Article Numbers 677471-677485: Florbetapir F 18 Injection, Amyvid, FDA Approval Package for NDA 202008. FDA Approval Package 2012.

Article Numbers 677455-677470: Peginesatide, Omontys Injection, FDA Approval Package for NDA 202799. FDA Approval Package 2012.


ADVISORY COMMITTEE MEETINGS

Article Numbers 677831-677836: Antiviral Drugs Advisory Committee Meeting, May 10, 2012. FDA Advisory Committee 2012.

Article Numbers 677825-677830: Reproductive Drugs Advisory Committee, April 5, 2012. FDA Advisory Committee 2012.

Article Numbers 677681-677687: Endocrinologic and Metabolic Drugs Advisory Committee Meeting, May 10, 2012. FDA Advisory Committee 2012.

Article Numbers 677674-677680: Arthritis Drugs Advisory Committee, May 9, 2012. FDA Advisory Committee 2012.

Article Numbers 677668-677673: Arthritis Advisory Committee, May 8, 2012. FDA Advisory Committee 2012.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 677271: Lipsky B A, Berendt A R, Cornia P B, Pile J C, et al. 2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections (Ref Art 677255). Clin Infect Dis 2012, 54:E132-E173.


CONTINUING EDUCATION ARTICLES

Article Number 677334: Cada D J, Demaris K, Levien T L, Baker D E. Aflibercept (0.15 CEU). Hosp Pharm 2012, 47:375-379.

Article Number 677048: Anonymous. Fentanyl Sublingual Spray (Subsys) for Breakthrough Cancer Pain (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 677046-677048]. Med Lett Drugs Ther 2012, 54:39-40.

Article Number 677047: Anonymous. Linagliptin/Metformin (Jentadueto) for Type 2 Diabetes (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 677046-677048]. Med Lett Drugs Ther 2012, 54:37-39.

Article Number 677046: Anonymous. Off-Label Use of Ketorolac for Athletic Injuries (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 677046-677048]. Med Lett Drugs Ther 2012, 54:37.

Article Number 676405: Anonymous. Drugs for Rheumatoid Arthritis (0.2 CEU). Treat Guidel Med Lett 2012, 10:37-44.


College of Pharmacy